Detalles de la búsqueda
1.
Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
BMC Endocr Disord;
23(1): 68, 2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36973824
2.
Effects of Long-Acting Somatostatin Analogues on Lipid Metabolism in Patients with Newly Diagnosed Acromegaly: A Retrospective Study of 120 Cases.
Horm Metab Res;
54(1): 25-32, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986497
3.
Decreased Serum Wnt Antagonist Levels in Patients With Active Acromegaly.
Endocr Pract;
28(5): 515-520, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123069
4.
A study on serum pro-neurotensin (PNT), furin, and zinc alpha-2-glycoprotein (ZAG) levels in patients with acromegaly.
J Endocrinol Invest;
45(10): 1945-1954, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670958
5.
Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide after Growth Hormone-Releasing Hormone Stimulation.
J Pharmacol Exp Ther;
379(3): 400-408, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599040
6.
Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
BMC Endocr Disord;
21(1): 90, 2021 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933067
7.
A Pituitary Society update to acromegaly management guidelines.
Pituitary;
24(1): 1-13, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079318
8.
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly.
Pituitary;
24(2): 170-183, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33124000
9.
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment.
Pituitary;
24(2): 242-251, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164134
10.
First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence.
J Endocrinol Invest;
44(11): 2427-2433, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837920
11.
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience.
J Endocrinol Invest;
44(12): 2593-2599, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34018167
12.
GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly.
Endocr J;
68(8): 953-968, 2021 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33840669
13.
Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies.
BMC Endocr Disord;
20(1): 126, 2020 Aug 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32811475
14.
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review.
Pituitary;
23(5): 582-594, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602066
15.
The haemostatic system in acromegaly: a single-centre case-control study.
J Endocrinol Invest;
43(7): 1009-1018, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994012
16.
Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study.
J Endocrinol Invest;
43(4): 529-538, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31741320
17.
Associations between circulating bone-derived hormones lipocalin 2, osteocalcin, and glucose metabolism in acromegaly.
J Endocrinol Invest;
43(9): 1309-1316, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198716
18.
Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.
J Endocrinol Invest;
43(2): 163-171, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392573
19.
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients.
J Endocrinol Invest;
43(11): 1661-1667, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333332
20.
Changes in cardiovascular risk factors in patients with acromegaly after trans-sphenoidal adenomectomy.
Endocr J;
67(12): 1169-1177, 2020 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32713864